NEW YORK (GenomeWeb News) – SomaLogic has named Byron Hewett to be its new CEO, effective Dec. 2. Hewett takes over the top spot for Larry Gold, who will continue serving in his other post as chairman of the board and working full-time as an adviser.

Hewett most recently was chairman and CEO of Biobehavioral Diagnostics, and he previously was president and CEO of Immunicon and senior VP of sales and marketing and GM, North America for Qiagen. He also has held leadership posts at Abbott Diagnostics, Chiron/Bayer, and BioCircuits.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.